Costume Umeki ufficio postale cappellini and thalassemia treatments haematologica 2017 Albero Maturare sabbioso
JCM | Free Full-Text | Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia?
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
Thalassemia Reports | Free Full-Text | CRISPR Gene Therapy: A Promising One-Time Therapeutic Approach for Transfusion-Dependent β-Thalassemia—CRISPR-Cas9 Gene Editing for β-Thalassemia
Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu
Introductory Chapter: β-Thalassemia | IntechOpen
Frontiers | The Future of Gene Therapy for Transfusion-Dependent Beta- Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells
IJMS | Free Full-Text | Thalassemia Intermedia: Chelator or Not?
Blood Demand and Challenges for Patients With Beta-Thalassemia Major in Eastern Saudi Arabia | Article - Cureus
Novel genetic therapeutic approaches for modulating the severity of β‑ thalassemia (Review)
Medicina | Free Full-Text | Non-Transfusion-Dependent Thalassemia: A Panoramic Review
Coordinated β-globin expression and α2-globin reduction in a multiplex lentiviral gene therapy vector for β-thalassemia: Molecular Therapy
Pediatric Thalassemia: Practice Essentials, Background, Pathophysiology
Luspatercept for the treatment of β-thalassemia: from preclinical research to clinical practice and beyond | Future Rare Diseases
Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine | Scientific Reports
Β-Thalassemias | NEJM
Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia
Frontiers | Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene
Survival and complications in patients with haemoglobin E thalassaemia in Sri Lanka: a prospective, longitudinal cohort study - The Lancet Global Health
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica
IJMS | Free Full-Text | Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis
Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation | SpringerLink
Cureus | Improving Ineffective Erythropoiesis in Thalassemia: A Hope on the Horizon | Article